WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a 1-for-50 reverse stock split of its common ...

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat ...

The current stock market resembles a still lake with perilous currents swirling beneath the surface.Judging by the S&P 500’s ...

The Securities and Exchange Commission (SEC) recently approved rule changes proposed by The Nasdaq Stock Market LLC that impact companies ...

January 2025, the U.S. Securities and Exchange Commission (SEC) approved amendments, both of which are now effective, to The Nasdaq Stock Market ...

Software stock Cyngn Inc (NASDAQ:CYN) is near the bottom of the Nasdaq, down 34.2% at $9.12, after the company announced a 150-for-1 reverse stock split. On track for its fifth-straight loss, CYN is ...

Effective this morning (Tuesday, February, 18, 2025) Nexxen's New Ordinary Shares began trading on Nasdaq under the stock ticker "NEXN” (ISIN: IL0012165630 and CUSIP: M8T80P204). Shareholders who ...

Windtree Therapeutics (WINT) board of directors has approved a 1-for-50 reverse stock split of the Company’s common stock. The Company’s ...

Windtree Therapeutics, Inc. (NasdaqCM: WINT) (“Windtree” or the “Company”), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...